These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26642766)

  • 21. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
    Yang B; Lin J; Chen Y; Liu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P; Li S; Wang L; Yang H; Yan J; Li H
    Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfadiazine/hydroxypropyl-beta-cyclodextrin host-guest system: Characterization, phase-solubility and molecular modeling.
    de Araújo MV; Vieira EK; Silva Lázaro G; Conegero LS; Almeida LE; Barreto LS; da Costa NB; Gimenez IF
    Bioorg Med Chem; 2008 May; 16(10):5788-94. PubMed ID: 18434167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
    Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 1H NMR Study of Host/Guest Supramolecular Complexes of a Curcumin Analogue with β-Cyclodextrin and a β-Cyclodextrin-Conjugated Gemini Surfactant.
    Poorghorban M; Karoyo AH; Grochulski P; Verrall RE; Wilson LD; Badea I
    Mol Pharm; 2015 Aug; 12(8):2993-3006. PubMed ID: 26083126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
    Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
    Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation.
    Ficarra R; Tommasini S; Raneri D; Calabrò ML; Di Bella MR; Rustichelli C; Gamberini MC; Ficarra P
    J Pharm Biomed Anal; 2002 Aug; 29(6):1005-14. PubMed ID: 12110385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of host-guest complexes of β-cyclodextrin and perfluorooctanoic acid.
    Karoyo AH; Borisov AS; Wilson LD; Hazendonk P
    J Phys Chem B; 2011 Aug; 115(31):9511-27. PubMed ID: 21688796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
    Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving furosemide polymorphs properties through supramolecular complexes of β-cyclodextrin.
    Garnero C; Chattah AK; Longhi M
    J Pharm Biomed Anal; 2014 Jul; 95():139-45. PubMed ID: 24667568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, characterization and application of epichlorohydrin-β-cyclodextrin polymer.
    Gidwani B; Vyas A
    Colloids Surf B Biointerfaces; 2014 Feb; 114():130-7. PubMed ID: 24185192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of inclusion complex between 2,6-dinitrobenzoic acid and β-cyclodextrin by 1H NMR, 2D 1H NMR (ROESY), FT-IR, XRD, SEM and photophysical methods.
    Srinivasan K; Stalin T
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():105-15. PubMed ID: 24769381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
    de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
    Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.